Original language | English |
---|---|
Pages (from-to) | 3227-3229 |
Number of pages | 3 |
Journal | Journal of Allergy and Clinical Immunology: In Practice |
Volume | 9 |
Issue number | 8 |
DOIs | |
Publication status | Published - Aug 2021 |
Bibliographical note
Funding Information:Conflicts of interest: Dr van Doorn reports personal fees from Leopharma, grants and personal fees from Novartis, personal fees from Abbvie, personal fees from BMS, personal fees from Celgene, personal fees from Lilly, personal fees from MSD, personal fees from Pfizer, personal fees from Sanofi-Genzyme, and personal fees from Janssen Cilag, outside the submitted work. The rest of the authors declare that they have no relevant conflicts of interest.